News & Events
Kiss Goodbye to MS launches
The exciting new international fundraising campaign for MS has officially begun!
Radiologically isolated syndrome (RIS) and primary progressive multiple sclerosis (PPMS)
People with RIS evolve to PPMS at the same frequency as expected from general MS populations
Oral steroids as good as intravenous in treating relapses
New data supports the use of oral steroid methylprednisolone to treat MS relapses
Controversial results from a new vitamin D study
New research shows no association between increasing blood vitamin D levels and reduced inflammation in relapsing-remitting MS
Sexual dysfunction is common in MS
Sexual dysfunction is a common but often overlooked and undertreated symptom in MS
Consultant wanted: evidence review on quality of life & MS
An exciting opportunity has arisen to work with us on a project to refresh 'the Principles to…
23 answers on predicting disease progression and MRI
MS researcher Arman Eshaghi answers questions from around the world
Kiss Goodbye to MS goes global
An exciting new international fundraising campaign for MS is coming your way
Results from a long-term observational study on MS
Long-term follow-up studies could help determine predictive factors for long-term clinical outcomes
Improving clinical trial designs in MS
Study suggests that longer observation time is necessary for more reliable results
Recommended treatment after stopping natalizumab
Switching from natalizumab to an alternative drug may prevent disease reactivation
Your chance to ask a young researcher about his work
Arman Eshaghi will answer your questions